Drug intelligence / Profile preview

[68Ga]Ga-NYM096

Development stage
Unknown
Lead developer
Peking Union Medical College Hospital
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[68Ga]Ga-NYM096 is a radiopharmaceutical small molecule designed for positron emission tomography (PET) imaging of tumors expressing carbonic anhydrase IX (CAIX/CA9). Developed by Peking Union Medical College Hospital in collaboration with Norroy Bioscience, it is a next-generation CAIX-targeting agent with significantly higher affinity (approximately 100-fold) compared to its predecessor, NYM005. It is primarily being investigated for the detection and evaluation of primary and metastatic clear cell renal cell carcinoma (ccRCC), particularly in patients who have progressed on standard tyrosine kinase inhibitor (TKI) or immune checkpoint inhibitor therapies. As part of a theranostic pair, it serves as the diagnostic companion to the therapeutic agent [177Lu]Lu-NYM096.

Other names
68Ga-NYM096
02

Targets

CA9 (Carbonic anhydrase IX)

Beyond the preview

Go deeper on [68Ga]Ga-NYM096.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [68Ga]Ga-NYM096.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call